Lv35
275 积分 2022-03-03 加入
Geroscience
4小时前
已完结
The next generation of immunotherapies for lung cancers
11天前
已完结
Dual-payload ADCs move into first oncology clinical trials
11天前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
11天前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
11天前
已完结
The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation
11天前
已完结
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
11天前
已完结
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
11天前
已完结
Ovarian Cancer A Review
12天前
已完结
皖公网安备34019202002308
